Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Dechra Pharmaceuticals PLC banner
D

Dechra Pharmaceuticals PLC
F:1PK0

Watchlist Manager
Dechra Pharmaceuticals PLC
F:1PK0
Watchlist
Price: 85.5 EUR Market Closed
Market Cap: €4.9B
Write Note Create Alert Ask AI

Wall St Price Targets

1PK0 Price Targets Summary
Dechra Pharmaceuticals PLC

There are no price targets for 1PK0.
1PK0 Lowest Forecast
Not Available
1PK0 Average Forecast
Not Available
1PK0 Highest Forecast
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Dechra Pharmaceuticals PLC Competitors:
Price Targets
KRUS
Kura Sushi USA Inc
36% Upside
KRUS
Kura Sushi USA Inc
36% Upside

Revenue
Forecast

18% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
18% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

18% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
18% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Dechra Pharmaceuticals PLC

Operating Income
Forecast

-1% / Year
Past Growth
98% / Year
Estimated Growth
Estimates Accuracy
-48%
Average Miss
-1% / Year
Past Growth
98% / Year
Estimated Growth
Estimates Accuracy
-48%
Average Miss

Over the last 8 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 98%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Dechra Pharmaceuticals PLC

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss

What are analyst estimates?

Continue 1PK0 Research

Summary
1PK0 intrinsic value, competitors valuation, and company profile.
DCF Valuation
1PK0 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
1PK0 stock valuation using valuation multiples.
Wall St Estimates
1PK0 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
1PK0 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Dechra Pharmaceuticals PLC listings:
F • EUR
1PK
 SWB • EUR
1PK
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1PK0's stock price target?
Not Available

1PK0 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Dechra Pharmaceuticals PLC?
Projected CAGR
9%

Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Dechra Pharmaceuticals PLC?
Projected CAGR
98%

Over the last 8 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 98%.

Back to Top
ALPHA SPREAD
Follow us
Join 345,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett